p53 gene mutations are frequently detected in esophageal cancer [9], and dysregulation of cell regulators, such as epidermal growth factor receptor [10, 11], HER-2/Neu [12], and vascular endothelial growth factor [13], has been investigated in ESCC. The gene discussed is ERBB2; the disease is esophageal squamous cell carcinoma.